Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal SMAD1 Primary Antibody for WB - ABIN1881815
Ye, Yu, Hu, Lu, Xie: Alterations of dendritic cell subsets in the peripheral circulation of patients with cervical carcinoma. in Journal of experimental & clinical cancer research : CR 2010
Show all 4 Pubmed References
Human Polyclonal SMAD1 Primary Antibody for WB - ABIN3042628
Tao, Hu, Li, Liu, Wu, Li, Fu, Wei, Luo: Tranilast prevents the progression of chronic cyclosporine nephrotoxicity through regulation of transforming growth factor ?/Smad pathways. in Transplantation proceedings 2011
Show all 3 Pubmed References
Human Polyclonal SMAD1 Primary Antibody for WB - ABIN967044
Zhu, Kavsak, Abdollah, Wrana, Thomsen: A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. in Nature 1999
Human Monoclonal SMAD1 Primary Antibody for IF, IHC (p) - ABIN517610
Nakajima, Yanagihara, Nishii: Temporal and regional patterns of Smad activation in the rat hippocampus following global ischemia. in Journal of the neurological sciences 2014
Human Polyclonal SMAD1 Primary Antibody for WB - ABIN362414
Yamaguchi, Zhu, Yu, Sasaki, Umetsu, Kidachi, Ryoyama et al.: Serum-free mouse embryo cells generate a self-sustaining feedback loop for an astrocyte marker protein and respond to cytokines and bisphenol A in accordance with the subtle difference in their ... in Cell biology international 2007
Data show that interplay of Smad1/5 and MAP kinase (show MAPK1 Antibodies) signaling system (ERK (show MAPK1 Antibodies) signalling) is essential for haemogenic endothelium-based haematopoietic stem cell emergence.
this study uncovers that smad1 and smad9 (show SMAD9 Antibodies) act redundantly to each other downstream of smad5 (show SMAD5 Antibodies) to mediate ventral specification and to regulate embryonic myelopoiesis.
that specificity of BMP signaling output, with respect to hematopoiesis, can be explained by differential functions of Smad1 and Smad5 (show SMAD5 Antibodies).
This report provides a genetic analysis of primary nociceptive neuron mechanisms that promote sensitization in response to injury. Drosophila melanogaster larvae whose primary nociceptive neurons were reduced in levels of specific components of the BMP signaling pathway, were injured and then tested for nocifensive responses to a normally subnoxious stimulus.
LTR sequence of the MDG4 (show MOD(MDG4) Antibodies) retrotransposon contains the MAD protein (show MXD1 Antibodies) binding site that affects the east-dependent repression
we identify key roles for the Zelda and Zerknullt transcription factors in establishing the resulting expression domain, and find widespread binding of insulator proteins to the Mad and Brinker-bound genomic regions. Analysis of embryos lacking the BEAF-32 insulator protein shows reduced transcription of a peak BMP target gene and a reduction in the number of amnioserosa cells, the fate specified by peak BMP signaling.
Mad linker phosphorylations control the intensity and range of the BMP-activity gradient in developing Drosophila tissues.
During development, synaptic pMad accumulation followed the arrival and clustering of ionotropic glutamate (show GRIN2A Antibodies) receptors at neuromuscular junction synapses.
The actions of Brat at synapses are mediated through mothers against decapentaplegic (Mad), the signal transduction effector of the bone morphogenetic protein (BMP) signaling pathway.
Mad has distinct signal transduction roles in the BMP (show TGFb Antibodies) and Wnt (show WNT4 Antibodies) pathways depending on its phosphorylation state.
Yorkie (show YAP1 Antibodies) and Mad physically bind each other, and 410 bp minimal enhancer of bantam that responds to Yorkie:Mad in vivo and in cultured cells, was identified.
Heterodimers of SAX and TKV play an important role in extending the BMP activity gradient by facilitating DPP diffusion and assisting GBB signaling through functional complexes with type II receptors.
importin-beta11 function interacts with the bone morphogenic protein (show TGFb Antibodies) pathway to regulate a pool of phosphorylated mothers against decapentaplegic that must be present at the presynapse for its proper development and function
the expression of BMP15 (show BMP15 Antibodies) in follicular fluid and Smad1 (show GARS Antibodies) in granulosa cells was significantly decreased in the PCOS group compared with the control (P<0.05). The data suggested that the BMP15 (show BMP15 Antibodies)/Smad1 (show GARS Antibodies) signalling pathway may be involved in granulosa cell apoptosis
Mechanical stress affects the osteogenic differentiation of human ligamentum flavum cells via the BMP-Smad1 (show GARS Antibodies) signaling pathway.
Urinary Smad1 (show GARS Antibodies) was associated with the degree of mesangial expansion in early diabetic nephropathy.
Differential expression of TGF-beta (show TGFB1 Antibodies) superfamily members and role of Smad1 (show GARS Antibodies)/5/9-signalling in chondral versus endochondral chondrocyte differentiation.
Uev1A (show UBE2V1 Antibodies) appears to be involved in the BMP signaling pathway in which it collaborates with a ubiquitin E3 ligase Smurf1 (show SMURF1 Antibodies) to promote Smad1 (show GARS Antibodies) degradation in a Ubc13 (show UBE2N Antibodies)-independent manner.
Data show that miR (show MLXIP Antibodies)-26b-5p suppresses Twist1 (show TWIST1 Antibodies)-induced EMT (show ITK Antibodies), invasion, and metastasis of HCC (show FAM126A Antibodies) cells by targeting SMAD1 (show GARS Antibodies).
Testosterone promoted tube formation of human umbilical endothelial cells, which was blocked by c-Src (show SRC Antibodies) and ERK1/2 inhibitors or by the knockdown of Smad1 (show GARS Antibodies).
Low doses of IL1B (show IL1B Antibodies) activate the BMP/Smad signaling pathway to promote the osteogenesis of periodontal ligament stem cells, but higher doses of IL1B (show IL1B Antibodies) inhibit BMP/Smad signaling through the activation of NF-kappaB (show NFKB1 Antibodies) and MAPK (show MAPK1 Antibodies) signaling, inhibiting osteogenesis.
Store operated calcium entry negatively regulates the Smad1 (show GARS Antibodies) signaling pathway and inhibits Col (show HDAC1 Antibodies) IV protein production in glomerular mesangial cells.
A significant association was found between the low expression of inhibitory protein SMAD-7 (show SMAD7 Antibodies) and both zeta-chain-associated protein kinase (show CDK7 Antibodies) 70-negative cells (p = 0.04) and lower apoptotic index (p = 0.004). No differences were observed in SMAD-2 (show SMAD2 Antibodies)/3 expression. In conclusion, our results demonstrate a significant correlation between greater SMAD-1 (show GARS Antibodies)/8 and lower SMAD-4 (show SMAD4 Antibodies) expression in chronic lymphocytic leukemia cells
Results show that Smad1 plays an important role in the development of glomerular injury without affecting cell proliferation, in progressive glomerulonephritis.
These findings uncover crosstalk between the BMP-Smad1 and RANKL (show TNFSF11 Antibodies)-NF-kappaB (show NFKB1 Antibodies) pathways during osteoclastogenesis that underlies the action of active vitamin D on bone health.
CD137 (show TNFRSF9 Antibodies) signaling is a new regulator of angiogenesis by modulating the Smad1/5-NFATc1 (show NFATC1 Antibodies) pathway.
TGF-beta1 (show TGFB1 Antibodies)-induced pSmad1 levels were elevated in Nedd4-deficient primary VSMCs isolated from Nedd4(fl/fl (show FLT3LG Antibodies)) ;SM22alpha (show TAGLN Antibodies)-Cre mice.
AA-enhanced cardiomyogenesis thus relies on the ability of AA to modulate the ratio of SMAD signaling among the TGFbeta (show TGFB1 Antibodies)-superfamily receptor signaling pathways
Sphingosine 1 phosphate also up-regulated runt-related transcription factor 2 (Runx2 (show RUNX2 Antibodies)) expression through S1PR2 (show S1PR2 Antibodies)/RhoA (show RHOA Antibodies)/ROCK/Smad1/5/8 signaling.
these results identify the PI3K-GSK3-SMAD1 axis as a central node integrating multiple signaling networks that govern bone formation and homeostasis.
We discovered that Smad1/5/4-Amhr2 (show AMHR2 Antibodies)-cre KO females have malformed oviducts that subsequently develop oviductal diverticuli. In addition, uteri from Smad1/5/4-Amhr2 (show AMHR2 Antibodies)-cre KO females exhibit multiple defects in stroma, epithelium, and smooth muscle layers and fail to assemble a closed uterine lumen upon embryo implantation, with defective uterine decidualization that led to pregnancy loss at early to mid-gestation.
these studies characterize an accessory TGF-beta (show TGFB1 Antibodies)-stimulated BMP R-Smad signaling mechanism in interstitial cells of the developing lung.
these results identify a novel function of YAP (show YAP1 Antibodies) in neocortical astrocytic differentiation and proliferation, and reveal a BMP2 (show BMP2 Antibodies)-YAP (show YAP1 Antibodies)-SMAD1 pathway underlying astrocytic differentiation in the developing mouse neocortex.
interactions between miR (show MYLIP Antibodies)-26 and the Smad1 3'UTR (show UTS2R Antibodies) modulate Smad1 function in the establishment of axial patterning.
a detailed computational model for TGF-beta (show TGFB1 Antibodies) signalling that incorporates elements of previous models together with crosstalking between Smad1/5/8 and Smad2 (show SMAD2 Antibodies)/3 channels through a negative feedback loop dependent on Smad7 (show SMAD7 Antibodies).
The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed.
MAD homolog 1
, SMAD, mothers against DPP homolog 1
, mothers against decapentaplegic homolog 1
, mothers against decapentaplegic-like protein 1
, MAD (mothers against decapentaplegic, Drosophila) homolog 1
, SMA- and MAD-related protein 1
, SMAD 1
, SMAD family member 1
, mothers against DPP homolog 1
, mother against decapentaplegic
, mothers against decapentaplegi
, mothers against decapentaplegic
, mothers against dpp
, phosphorylated smad
, MAD, mothers against decapentaplegic homolog 1
, Mad-related protein 1
, TGF-beta signaling protein 1
, transforming growth factor-beta signaling protein 1
, transforming growth factor-beta-signaling protein 1
, Smad 1
, mad-related protein 1
, mothers-against-DPP-related 1
, MAD homolog1 (mothers against decapentaplegic, Drosophila)
, mothers against DPP
, BMP pathway effector
, BMP signal transducer Smad1
, Sma- and Mad-related protein 1